# Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer

> **NCT03077282** · PHASE1 · COMPLETED · sponsor: **Thammasat University** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Prasaprohyai

## Key facts

- **NCT ID:** NCT03077282
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-26
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-14
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03077282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03077282, "Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03077282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*